Modiin, Israel

Daniel Naor

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sonivie Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Naor. Retrieved from https://idiyas.com/inventor/daniel-naor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Naor

Introduction

Daniel Naor is an accomplished inventor based in Modiin, Israel. He has made significant contributions to the field of medical technology, particularly in respiratory health. With a total of 2 patents, Naor's work focuses on innovative methods to improve patient outcomes.

Latest Patents

Naor's latest patents include devices and methods for reducing parasympathetic nerve activity in patients with respiratory syndromes. One embodiment relates to a method that aims to reduce excess mucosa production and/or secretion in the respiratory tract. This method involves introducing a device into the respiratory tract lumen, which is designed to damage nerve tissue or block neural conduction. The device comprises a plurality of energy emitters that are positioned inside the lumen at a distance from its walls. By activating these energy emitters, the device emits energy suitable to damage the nerve tissue enough to suppress parasympathetic nerve activity, which is responsible for excess mucosa production and/or secretion.

Another patent by Naor also focuses on reducing parasympathetic nerve activity in patients with respiratory syndromes. This method involves introducing a device into the lumen of the trachea or bronchi, which is configured to damage nerve tissue or block neural conduction. The device is activated to damage the nerve tissue sufficiently to suppress the parasympathetic nerve activity that leads to excess mucosa production and/or secretion.

Career Highlights

Daniel Naor is currently associated with Sonivie Ltd., where he continues to develop innovative solutions in the medical field. His work has garnered attention for its potential to significantly improve the quality of life for patients suffering from respiratory issues.

Collaborations

Naor has collaborated with notable professionals in his field, including Charles S. Carignan and Or Shabtay. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Daniel Naor's contributions to medical technology, particularly in respiratory health, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to finding effective solutions for complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…